References
- Garg A. Acquired and inherited lipodystrophies. N Engl J Med. 2004;350(12):1220–34. doi:10.1056/NEJMra025261.
- Hegele RA, Cao H, Liu DM, Costain GA, Charlton-Menys V, Rodger NW, Durrington PN. Sequencing of the reannotated LMNB2 gene reveals novel mutations in patients with acquired partial lipodystrophy. Am J Hum Genet. 2006;79(2):383–89. doi:10.1086/505885.
- Ajluni N, Dar M, Xu J, Neidert AH, Oral EA. Efficacy and safety of metreleptin in patients with partial lipodystrophy: lessons from an expanded access program. J Diabetes Metab. 2016;7(3):659.
- Moyle GJ, Brown S, Lysakova L, Barton SE. Long-term safety and efficacy of poly-L-lactic acid in the treatment of HIV-related facial lipoatrophy. HIV Med. 2006;7:181–85. doi:10.1111/j.1468-1293.2006.00342.x.
- Approved medical devices for the treatment of complications of HIV/AIDS. U.S. food & drug administration website. Last updated 2009. https://www.fda.gov/ForPatients/Illness/HIVAIDS/Treatment/ucm118954.htm